AstraZeneca opens research centre as UK builds science hub
The Hindu
The centre is near the University of Cambridge
Prince Charles will be on hand on Tuesday when pharmaceutical company AstraZeneca opens a 1 billion-pound ($1.34 billion) research centre near the University of Cambridge, hoping to build on work in developing one of the first COVID-19 vaccines.
The 19,000 square-meter (more than 200,000 square-foot) complex will house more than 2,200 research scientists. It joins a cluster of businesses seeking to make Cambridge a hub for life sciences research similar to what California's Silicon Valley is for the technology industry.
“Our ambition today is to not only unveil a building, but to also drive the next wave of scientific innovation,” CEO Pascal Soriot said in a statement.
EU and Israel in war of words as ties nosedive ahead of Spain, Ireland recognizing Palestinian state
EU-Israel relations strained over Palestinian state recognition, with threats of sanctions and ICC involvement in conflict.